|
|
Post by longliner on Apr 6, 2021 15:47:45 GMT -5
|
|
|
|
Post by hellodolly on Apr 6, 2021 16:01:49 GMT -5
3/15 (20%) What do you make of the hypoglycemia. Normal considering the very rigid dosing requirements? |
|
|
|
Post by porkini on Apr 6, 2021 20:54:45 GMT -5
3/15 (20%) What do you make of the hypoglycemia. Normal considering the very rigid dosing requirements? Don't know about either of those, but I'm concerned about Flank Pain. What, are we sitting on our whistles?   |
|
|
|
Post by prcgorman2 on Apr 7, 2021 6:04:29 GMT -5
3/15 (20%) What do you make of the hypoglycemia. Normal considering the very rigid dosing requirements? Don't know about either of those, but I'm concerned about Flank Pain. What, are we sitting on our whistles? Interesting read but completely unable to guess how that gets reviewed/interpreted. As for flank pain, I wonder where the “multiple injections of basal” were administered.  |
|
|
|
Post by anderson on Apr 7, 2021 9:20:43 GMT -5
3/15 (20%) What do you make of the hypoglycemia. Normal considering the very rigid dosing requirements? Since it was listed in the "other(not including serious)" adverse events they must have been not been serious cases. Didn't see any data on what level they considered Hypoglycemia or Hyperglycemia, but there were 93 events total so 24 people completed the trial so 3 meals a day for 30 days is 90 meals per person so 2160 meals total and 93 Hypoglycemia event....4.3%. Also timing isn't mentioned, were they all clustered at the beginning of the trial, or were they spread out over the trial. Lots of data missing to be able to draw a conclusion from this document. |
|
|
|
Post by hellodolly on Apr 7, 2021 9:52:51 GMT -5
3/15 (20%) What do you make of the hypoglycemia. Normal considering the very rigid dosing requirements? Since it was listed in the "other(not including serious)" adverse events they must have been not been serious cases. Didn't see any data on what level they considered Hypoglycemia or Hyperglycemia, but there were 93 events total so 24 people completed the trial so 3 meals a day for 30 days is 90 meals per person so 2160 meals total and 93 Hypoglycemia event....4.3%. Also timing isn't mentioned, were they all clustered at the beginning of the trial, or were they spread out over the trial. Lots of data missing to be able to draw a conclusion from this document. Thanks for digging. |
|
|
|
Post by mango on Apr 9, 2021 9:11:49 GMT -5
Won’t be long ‘til we start seeing Pediatric Afrezza collages up like these. Diabetes is the dysregulation of blood glucose. Everyone with diabetes has one thing in common, regardless of type—loss of the first phase insulin response. The first phase insulin response is a homeostatic mechanism that plays a critical role in maintaining glucose balance. Afrezza is the world’s only insulin that mimics the endogenous first phase insulin response like that seen in a healthy, non-diabetic person. Afrezza restores the first phase insulin response and thus restores post-prandial glucose homeostasis. Afrezza is a miracle. Welcome kids, to a life more humann.          |
|
|
|
Post by peppy on Apr 9, 2021 9:17:31 GMT -5
Mango. Sweet. Well said and an artist.
Afrezza, well documented.
Eyeballs required.
|
|
|
|
Post by mango on Apr 9, 2021 9:39:23 GMT -5
Yep, it’s well documented and so far proven to be the safest insulin on the market.
The pediatric market will love Afrezza and will create lifers.
Afrezza Pediatric Phase 3 starts this year.
|
|
